Filing Details
- Accession Number:
- 0001213900-21-022662
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-23 11:10:37
- Reporting Period:
- 2021-04-22
- Accepted Time:
- 2021-04-23 11:10:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 12239 | Aikido Pharma Inc. | AIKI | Services-Commercial Physical & Biological Research (8731) | 520849320 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1538372 | Anthony Hayes | One Rockefeller Plaza, 11Th Floor New York NY 10020 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-22 | 10,000 | $0.93 | 58,430 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
